Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2008
08/20/2008CN101245032A Leuco malachite green hapten, produced antibody and application of the antibody
08/20/2008CN100412196C Protection against environmental toxicity through manipulation of processing of messenger RNA precursors
08/20/2008CN100412193C Anti human CD19 mouse immune globulin variable zone gene and uses
08/20/2008CN100412092C Bacillus coli resisting chicken yolk antibody, its preparation and use
08/20/2008CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/19/2008US7414171 PD-1-lacking mouse and use thereof
08/19/2008US7414123 Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/19/2008US7414121 DNA sequence encoding an antibody fusion protein which is useful for the treatment and diagnosis of various cancers, including colon cancer; anticarcinogenic agents; biodrugs
08/19/2008US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections
08/19/2008US7414113 Increased ability to convert 5-fluorocytosine prodrug to its toxic form
08/19/2008US7414112 Of given sequence; conjugated to cytotoxic agent
08/19/2008US7414111 Engineered templates and their use in single primer amplification
08/19/2008US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody
08/19/2008US7414020 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein
08/19/2008US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents
08/19/2008US7413884 Using antibodies as hydrolysis catalysts; reducing concentration of amyloid plaque
08/19/2008US7413875 ESTs and encoded human proteins
08/19/2008US7413865 Determine number of hematopoietic cells of erythroid, megakaryocyte or platelets; comparing amount of ankyrin and glycophorin to standard
08/19/2008US7413741 HCV E1 comprising specific disulfide bridges
08/19/2008US7413737 Complementarity determining regions which bind to catalytic domain of aspartyl (asparaginyl) beta -hydroxylase; diagnosis and treatment of cancer; readily penetrates tumors, no side effects, less toxic
08/19/2008US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein
08/19/2008CA2578891A1 Medicaments for fungal infections
08/19/2008CA2351618C Protein amsh and cdna thereof
08/19/2008CA2311165C Improvements in or relating to electrochemical assays
08/19/2008CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
08/14/2008WO2008098115A2 Optimized igf-1r antibodies and methods of using the same
08/14/2008WO2008097870A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
08/14/2008WO2008097866A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
08/14/2008WO2008097817A2 Multivariable antigens complexed with targeting humanized monoclonal antibody
08/14/2008WO2008097812A1 Toxoplasma gondii oocyst protein
08/14/2008WO2008097585A2 Mutations in human ubiad1
08/14/2008WO2008097510A1 Antibodies specific for dkk-1
08/14/2008WO2008097467A1 Anti-methylation-controlled j protein antibodies and uses thereof
08/14/2008WO2008097439A2 Anti-autoimmune antibodies for treatment of pemphigus
08/14/2008WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
08/14/2008WO2008096817A1 Gaba neuron progenitor cell marker 65b13
08/14/2008WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND
08/14/2008WO2008096242A1 Antibodies specific for varicella zoster virus
08/14/2008WO2008096158A2 Antibody single variable domains against serum albumin
08/14/2008WO2008096131A1 Anti-pneumococcal capsular polysaccharide antibody molecules
08/14/2008WO2008095504A1 A polyclonal antibody product
08/14/2008WO2008045962A9 Methods and materials related to anti-a (beta) antibodies
08/14/2008WO2008034648A8 Process for the production of a fine chemical
08/14/2008WO2006107617A3 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
08/14/2008US20080194800 Human Receptor Proteins; Related Reagents and Methods
08/14/2008US20080194799 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties
08/14/2008US20080194798 Protein fixation; solid phase synthesis; biochips; immunohistochemistry
08/14/2008US20080194796 Methods for arbitrary peptide synthesis
08/14/2008US20080194477 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
08/14/2008US20080193980 Fusion protein of Fc-binding domain and calcium-binding photoprotein, gene encoding the same and use thereof
08/14/2008US20080193979 Using constitutive hypermutation by vairant DNA repair protein as tool in directed protein evolution
08/14/2008US20080193978 Using phage display libraries comprising light and heavy variable chains to generate immunoglobulins of preferential sensitivity
08/14/2008US20080193976 Pseudomonas Exotoxin A Cd4+T-Cell Epitopes
08/14/2008US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders
08/14/2008US20080193941 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/14/2008US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures
08/14/2008US20080193488 Variant Polypeptide and Screening Assay
08/14/2008US20080193470 Proteins and Nucleic Acids from Meningitis/Sepsis-Associated Escherichia Coli
08/14/2008US20080193469 Contraceptives Based on Sp22 and Sp22 Antibodies
08/14/2008US20080193467 Dendritic cell potentiation
08/14/2008US20080193466 Administering human antibody, or an antigen-binding fragment thereof, to subject, wherein antibody dissociates from human TNF alpha with a Kd of 1x10-8 M or less and a Koff rate constant of 1x10-3 s-1 or or less, and neutralizes human TNF alpha cytotoxicity with an IC50 of 1x10-7 M or less in L929 assay
08/14/2008US20080193465 Human Monoclonal Antibodies that Specifically Bind Igf-II
08/14/2008US20080193460 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer
08/14/2008US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
08/14/2008US20080193458 125p5c8: tissue specific protein highly expressed in various cancers
08/14/2008US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA)
08/14/2008US20080193455 Placental growth factor (PIGF) specific immunoglobulin for use in treatment and prevention of pathollogical angiogenesis
08/14/2008US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
08/14/2008US20080193453 Anti Tfr Antibody
08/14/2008US20080193451 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies
08/14/2008US20080193450 Antibodies Against Candida Antigens
08/14/2008US20080193449 Antibodies specific for DKK-1
08/14/2008US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
08/14/2008US20080193442 Inhibition of complement activation
08/14/2008US20080193441 Homogeneous Preparations of Chimeric Protein
08/14/2008US20080193439 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders
08/14/2008US20080193418 Antibodies coupled to detectable marker; lysis; decontaminate surface or organism; detect, prevent and treat infection
08/14/2008US20080193375 Lung cancer-targeted peptides and applications thereof
08/14/2008CA2715045A1 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
08/14/2008CA2715044A1 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
08/14/2008CA2715042A1 Multivariable antigens complexed with targeting humanized monoclonal antibody
08/14/2008CA2678194A1 Anti-human brak (cxcl14) monoclonal antibody and use thereof
08/14/2008CA2677996A1 Gaba neuron progenitor cell marker 65b13
08/14/2008CA2677371A1 Antibodies specific for varicella zoster virus
08/14/2008CA2677356A1 Antibodies specific for dkk-1
08/14/2008CA2677119A1 Mutations in human ubiad1
08/14/2008CA2677069A1 Antibody single variable domains against serum albumin
08/14/2008CA2676036A1 Hepcidin, hepcidin antagonists and methods of use
08/13/2008EP1956374A1 Detection and treatment of cancer
08/13/2008EP1956093A1 von Willebrand Factor (vWF)-cleaving protease
08/13/2008EP1956092A1 Mouse with a silenced lambda light chain locus
08/13/2008EP1956085A2 Carbohydrate crosslinked glycoprotein crystals
08/13/2008EP1956032A1 Monoclonal antibody directed against cd166 and method for production thereof
08/13/2008EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same
08/13/2008EP1956029A1 Vascular aging-predicting factor and utilization of the same
08/13/2008EP1954815A2 Production of glycoproteins with reduced o-glycosylation
08/13/2008EP1954720A1 Antibodies and immunotoxins that target human glycoprotein nmb
08/13/2008EP1954719A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
08/13/2008EP1954718A2 Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies